Universität zu Köln

Angermann, Christiane E., Assmus, Birgit, Anker, Stefan D., Brachmann, Johannes, Ertl, Georg, Koehler, Friedrich, Rosenkranz, Stephan, Tschoepe, Carsten, Adamson, Philip B. and Boehm, Michael (2018). Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF). Clin. Res. Cardiol., 107 (11). S. 991 - 1003. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-0692

Full text not available from this repository.

Abstract

BackgroundWireless monitoring of pulmonary artery (PA) pressures with the CardioMEMS HF system is indicated in patients with New York Heart Association (NYHA) class III heart failure (HF). Randomized and observational trials have shown a reduction in HF-related hospitalizations and improved quality of life in patients using this device in the United States.ObjectiveMEMS-HF is a prospective, non-randomized, open-label, multicenter study to characterize safety and feasibility of using remote PA pressure monitoring in a real-world setting in Germany, The Netherlands and Ireland.Methods and resultsAfter informed consent, adult patients with NYHA class III HF and a recent HF-related hospitalization are evaluated for suitability for permanent implantation of a CardioMEMS sensor. Participation in MEMS-HF is open to qualifying subjects regardless of left ventricular ejection fraction (LVEF). Patients with reduced ejection fraction must be on stable guideline-directed pharmacotherapy as tolerated. The study will enroll 230 patients in approximately 35 centers. Expected duration is 36 months (24-month enrolment plus12-month follow-up). Primary endpoints are freedom from device/system-related complications and freedom from pressure sensor failure at 12-month post-implant. Secondary endpoints include the annualized rate of HF-related hospitalization at 12 months versus the rate over the 12 monthspreceding implant, and health-related quality of life. Endpoints will be evaluated using data obtained after each subject's 12-month visit.ConclusionsThe MEMS-HF study will provide robust evidence on the clinical safety and feasibility of implementing haemodynamic monitoring as a novel disease management tool in routine out-patient care in selected European healthcare systems.Trial registrationClinicalTrials.gov; NCT02693691.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Angermann, Christiane E. UNSPECIFIED UNSPECIFIED UNSPECIFIED Assmus, Birgit UNSPECIFIED UNSPECIFIED UNSPECIFIED Anker, Stefan D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Brachmann, Johannes UNSPECIFIED UNSPECIFIED UNSPECIFIED Ertl, Georg UNSPECIFIED UNSPECIFIED UNSPECIFIED Koehler, Friedrich UNSPECIFIED UNSPECIFIED UNSPECIFIED Rosenkranz, Stephan UNSPECIFIED UNSPECIFIED UNSPECIFIED Tschoepe, Carsten UNSPECIFIED UNSPECIFIED UNSPECIFIED Adamson, Philip B. UNSPECIFIED UNSPECIFIED UNSPECIFIED Boehm, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-168196
DOI:	10.1007/s00392-018-1281-8
Journal or Publication Title:	Clin. Res. Cardiol.
Volume:	107
Number:	11
Page Range:	S. 991 - 1003
Date:	2018
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1861-0692
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language DISEASE-MANAGEMENT; MORTALITY; HOSPITALIZATIONS; TRANSITION; IMPACT Multiple languages Cardiac & Cardiovascular Systems Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/16819